Qualifyze in a $14 million funding round backed by HV Capital, Cherry Ventures, Rheingau Founders and APX

Qualifyze, a Frankfurt am Main, Germany-based operator of a marketplace for pharma competitive intel, announced completing a $14 million series A funding round.

The money was raised from investors from Germany led by HV Capital and joined by existing shareholders Cherry Ventures,  Rheingau Founders, Axel Springer Porsche, and Udo Jung.

Qualifyze, founded in 2017 as ChemSquare, part of a scientific doctorate at the Technical University of Darmstadt by David Schneider and Florian Hildebrand, works on a global, digital network in which customers, suppliers, auditors, subcontractors and authorities continuously and securely exchange quality data in order to make supply chains more transparent and secure.The company has a particular focus on the pharma industry, as it collects data from factories worldwide and makes it available to its customers once consent from the supplier has been obtained.

Qualifyze previously raised 3.2 million euros in 2020.